Colorectal cancer (CRC) is the third most common cancer worldwide and the fourth most common cause of death from cancer.
1 x 1 Ferlay, J, Shin, HR, Bray, F, Forman, D, Mathers, C, and Parkin, DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127: 2893–2917 Crossref | PubMed | Scopus (10570) | Google Scholar See all References
, 2 x 2 Siegel, R, Naishadham, D, and Jemal, A. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63: 11–30 Crossref | PubMed | Scopus (9464) | Google Scholar See all References Outcomes have improved with advances in surgical technique and adjuvant therapy. Mortality and survival rates in CRC are highly influenced by the stage of the disease at the moment of diagnosis: 5-year survival is excellent for disease localized to the colon (95% for stage I and 82% for stage II) but decreases to 61% for patients with regional spread to the lymph nodes (stage III) and to only 8% for patients with distant metastases (stage IV).
3 x 3 Parkin, DM, Bray, F, Ferlay, J, and Pisani, P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55: 74–108 Crossref | PubMed | Scopus (15604) | Google Scholar See all References
, 4 x 4 Hayat, MJ, Howlader, N, Reichman, ME, and Edwards, BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007; 12: 20–37 Crossref | PubMed | Scopus (616) | Google Scholar See all References These data confirm that early diagnosis of the primary tumor as well as the recurrences is crucial to improve overall and disease free survival.